Key result
Low predialysis systolic blood pressure (<120 mm Hg) and ambulatory blood pressure were identified as prognostic markers for mortality, with all-cause mortality varying from 12% to 36% across 13 studies.
Why the study?
What is the relationship between blood pressure measurements and mortality in hemodialysis patients?
Systematic Review
What is the relationship between blood pressure measurements and mortality in hemodialysis patients?
In hemodialysis patients, low predialysis systolic blood pressure (<120 mm Hg) is associated with increased mortality, and ambulatory blood pressure monitoring is recommended as the best predictor of cardiovascular mortality.
Answers are grounded in this paper and cite their sources.
BP targets in hemodialysis remain uncertain; leaves open optimal systolic thresholds for mortality risk.
Hypertension is prevalent in 75-80% of hemodialysis patients and remains the most controversial prognostic marker in end stage kidney disease patients. In contrast to the general population where systolic blood pressure of ≤120 mm Hg is considered normal, a debate remains regarding the ideal target blood pressure in hemodialysis patients. Using the PUBMED and EMBASE databases, the research studies that evaluated the relationship between blood pressure measurements and mortality in hemodialysis patients were searched. Thirteen studies were identified from different regions of the world. Five studies reported low predialysis systolic blood pressure as a prognostic marker of mortality. Other studies showed varying results and reported postdialysis systolic blood pressure as well as ambulatory blood pressure as better predictors of mortality and emphasized their optimized control. One study in this review concluded that there is no direct relationship between mortality and blood pressure if the patients are on anti-hypertensive medications. The observed all-cause mortality varied from 12% to 36%, whereas the cardiovascular mortality varied from 16% to 60%. On the basis of studies included in the current review, a low predialysis systolic blood pressure (<120 mm Hg) is shown to be a widely accepted prognostic marker of mortality while ambulatory blood pressure best predicts CV mortality. Therefore, we recommend that apart from routine BP (pre, post and intradialysis) monitoring in centers, assessment of ambulatory BP must be mandatory for all patients to reduce CV mortality in hemodialysis patients.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2016) conducted a systematic review in End stage kidney disease on hemodialysis. Blood pressure measurements (predialysis, postdialysis, and ambulatory) was evaluated on All-cause and cardiovascular mortality. Low predialysis systolic blood pressure (<120 mm Hg) and ambulatory blood pressure were identified as prognostic markers for mortality, with all-cause mortality varying from 12% to 36% across 13 studies.
Synapse has enriched 10 related papers. Consider them for comparative context: